• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.01%

    Titan Pharmaceuticals Inc. (TTNP)

    -OTC BB
    0.78 Up 0.00(0.13%) Jul 31, 3:58PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 3,646   10,481   7,117  
    Cost of Revenue -   -   -  
    Gross Profit 3,646   10,481   7,117  
    Operating Expenses
    Research Development4,075  8,309  10,610  
    Selling General and Administrative3,046  3,063  4,877  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (3,475) (891) (8,370)
    Income from Continuing Operations
    Total Other Income/Expenses Net1,072  12,170  (1,949)
    Earnings Before Interest And Taxes(2,403)11,279  (10,319)
    Interest Expense -  1,568  4,861  
    Income Before Tax(2,403)9,711  (15,180)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(2,403)9,711  (15,180)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (2,403) 9,711   (15,180)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (2,403) 9,711   (15,180)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.